Cite
Field JK, Vulkan D, Davies MPA, et al. Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis. Lancet Reg Health Eur. 2021;10:100179doi: 10.1016/j.lanepe.2021.100179.
Field, J. K., Vulkan, D., Davies, M. P. A., Baldwin, D. R., Brain, K. E., Devaraj, A., Eisen, T., Gosney, J., Green, B. A., Holemans, J. A., Kavanagh, T., Kerr, K. M., Ledson, M., Lifford, K. J., McRonald, F. E., Nair, A., Page, R. D., Parmar, M. K. B., Rassl, D. M., Rintoul, R. C., Screaton, N. J., Wald, N. J., Weller, D., Whynes, D. K., Williamson, P. R., Yadegarfar, G., Gabe, R., & Duffy, S. W. (2021). Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis. The Lancet regional health. Europe, 10100179. https://doi.org/10.1016/j.lanepe.2021.100179
Field, John K, et al. "Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis." The Lancet regional health. Europe vol. 10 (2021): 100179. doi: https://doi.org/10.1016/j.lanepe.2021.100179
Field JK, Vulkan D, Davies MPA, Baldwin DR, Brain KE, Devaraj A, Eisen T, Gosney J, Green BA, Holemans JA, Kavanagh T, Kerr KM, Ledson M, Lifford KJ, McRonald FE, Nair A, Page RD, Parmar MKB, Rassl DM, Rintoul RC, Screaton NJ, Wald NJ, Weller D, Whynes DK, Williamson PR, Yadegarfar G, Gabe R, Duffy SW. Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis. Lancet Reg Health Eur. 2021 Sep 11;10:100179. doi: 10.1016/j.lanepe.2021.100179. eCollection 2021 Nov. PMID: 34806061; PMCID: PMC8589726.
Copy
Download .nbib